Astrana Health (ASTH) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $55.00 from $47.00 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | $53.00 from $50.00 | Aug 7, 2026 |
| BTIG | Maintained | Buy | $65.00 from $50.00 | Jul 14, 2026 |
| TD Cowen | Maintained | Buy | $50.00 from $45.00 | Jul 14, 2026 |
| BTIG | Maintained | Buy | $50.00 | Jun 2, 2026 |
| Barclays | Upgraded | Equal-Weight → Overweight | $50.00 from $37.00 | May 26, 2026 |
| Truist Securities | Maintained | Buy | $47.00 from $38.00 | May 14, 2026 |
| TD Cowen | Maintained | Buy | $45.00 from $35.00 | May 12, 2026 |
| Barclays | Maintained | Equal-Weight | $37.00 from $26.00 | May 11, 2026 |
| BTIG | Maintained | Buy | $50.00 from $40.00 | May 8, 2026 |
| Needham | Maintained | Buy | $41.00 from $30.00 | May 8, 2026 |
| Baird | Maintained | Outperform | $40.00 from $37.00 | Apr 15, 2026 |
| Truist Securities | Maintained | Buy | $38.00 from $37.00 | Mar 13, 2026 |
| BTIG | Maintained | Buy | $40.00 from $45.00 | Feb 2, 2026 |
| Needham | Initiated Coverage | Buy | $28.00 | Dec 12, 2025 |
| Jefferies | Maintained | Buy | $37.00 from $44.00 | Nov 25, 2025 |
| Barclays | Maintained | Equal-Weight | $26.00 from $36.00 | Nov 24, 2025 |
| TD Cowen | Maintained | Buy | $35.00 from $40.00 | Nov 10, 2025 |
| BTIG | Maintained | Buy | $45.00 from $50.00 | Nov 7, 2025 |
| Barclays | Initiated Coverage | Equal-Weight | $36.00 | Apr 1, 2025 |
Frequently asked questions
What is the price target for ASTH stock?
The average 12-month analyst price target for Astrana Health (ASTH) is $55.75, with a high estimate of $65.00 and a low of $50.00, across 4 analysts.
Is ASTH a buy, sell, or hold?
Analysts covering Astrana Health currently average a Buy rating: 9 buy, 1 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ASTH?
The average price target of $55.75 implies 46.29% upside from the last price of $38.11.
What is the latest analyst rating on ASTH?
On Aug 11, 2026, Truist Securities maintained Astrana Health at Buy with a price target of $55.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.